Ensign Peak Advisors
HAE icon

Ensign Peak Advisors’s Haemonetics HAE Stock Holding History

Ensign Peak Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Hold
3,166
– – ﹤0.01% 1288
2026
Q1 		$178K Hold
3,166
– – ﹤0.01% 1359
2025
Q4 		$254K Sell
3,166
-6,100
-66% -$410K ﹤0.01% 1197
2025
Q3 		$452K Sell
9,266
-5,300
-36% -$328K ﹤0.01% 1424
2025
Q2 		$1.09M Hold
14,566
– – ﹤0.01% 1199
2025
Q1 		$926K Hold
14,566
– – ﹤0.01% 1304
2024
Q4 		$1.14M Hold
14,566
– – ﹤0.01% 1242
2024
Q3 		$1.17M Hold
14,566
– – ﹤0.01% 1231
2024
Q2 		$1.21M Hold
14,566
– – ﹤0.01% 1164
2024
Q1 		$1.24M Sell
14,566
-735
-5% -$57.7K ﹤0.01% 1176
2023
Q4 		$1.31M Buy
15,301
+950
+7% +$82.1K ﹤0.01% 1176
2023
Q3 		$1.29M Hold
14,351
– – ﹤0.01% 1019
2023
Q2 		$1.22M Hold
14,351
– – ﹤0.01% 1111
2023
Q1 		$1.19M Buy
14,351
+200
+1% +$16.2K ﹤0.01% 1105
2022
Q4 		$1.11M Sell
14,151
-2,500
-15% -$201K ﹤0.01% 1077
2022
Q3 		$1.23M Sell
16,651
-190
-1% -$13.6K ﹤0.01% 965
2022
Q2 		$1.1M Hold
16,841
– – ﹤0.01% 1072
2022
Q1 		$1.06M Hold
16,841
– – ﹤0.01% 1161
2021
Q4 		$893K Sell
16,841
-24,530
-59% -$1.49M ﹤0.01% 1357
2021
Q3 		$2.92M Hold
41,371
– – 0.01% 897
2021
Q2 		$2.76M Hold
41,371
– – 0.01% 937
2021
Q1 		$4.59M Sell
41,371
-9,993
-19% -$1.24M 0.01% 660
2020
Q4 		$6.1M Sell
51,364
-1,300
-2% -$140K 0.01% 546
2020
Q3 		$4.59M Hold
52,664
– – 0.01% 655
2020
Q2 		$4.72M Hold
52,664
– – 0.01% 622
2020
Q1 		$5.25M Buy
52,664
+8,593
+19% +$932K 0.02% 500
2019
Q4 		$5.06M Buy
+44,071
New +$5.33M 0.01% 640

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ensign Peak Advisors's HAE Position: Q2 2026 in Review

Ensign Peak Advisors held its Haemonetics (HAE) position steady in Q2 2026 at 3,166 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Ensign Peak Advisors first reported a position in HAE in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.1M in Q4 2020. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Ensign Peak Advisors held 3,166 shares of Haemonetics worth $237K as of Q2 2026.
  • Ensign Peak Advisors left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1288 holding.
  • Ensign Peak Advisors first reported a position in Haemonetics in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Haemonetics position peaked at $6.1M in Q4 2020.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.